With decades of experience and a future-focused mindset, we support clients with accurate testing, custom research, and expert consultation. From life sciences to environmental monitoring, we deliver clarity through science.
Vijaymala Clinical Laboratory Services LLP is a healthcare innovation start-up dedicated to developing low-cost, accessible diagnostic platforms. Our mission is to translate breakthrough research into real-world healthcare solutions, ensuring early detection and impactful care, especially in low-resource settings.
TB Diagnostics
Point-of-Care
Healthcare Innovation
Affordable Solutions
Clinical Research
Biotech Innovation
Early Detection
Translational Research
Infectious Diseases
TB Diagnostics
Point-of-Care
Healthcare Innovation
Affordable Solutions
Clinical Research
Biotech Innovation
Early Detection
Translational Research
Infectious Diseases
Vijaymala Clinical Laboratory Services LLP is a healthcare innovation start-up focused on developing affordable point-of-care diagnostic platforms for tuberculosis (TB) and other infectious diseases.
We are a spin-off from:
• Maharashtra State Innovation Society (MSInS), Mumbai
• D Y Patil deemed to be University, Kolhapur
We are incubated at the Yenepoya Technology Incubator (YTI), which provides us with regulatory and translational support. This collaboration strengthens our ability to bring cutting-edge research into clinically relevant diagnostic solutions.
Additionally, we are supported by the SUK Research and Development Foundation (SUKRDF), Shivaji University, Kolhapur (a Section-8 company).
We focus on developing innovative diagnostic platforms that are low-cost, reliable, and scalable for widespread healthcare impact. Our solutions are designed to improve early detection, disease management, and patient care across diverse environments.
Affordable diagnostic platforms for TB and infectious diseases.
Innovative molecular tools for rapid, accurate detection of pathogens.
Accurate laboratory testing services to support patient care and research.
Innovating affordable diagnostics to reach every community
We aim to bridge the gap between academic research and real-world healthcare impact. Too often, promising innovations remain as Ph.D. theses or publications without translation. Our start-up is committed to converting these ideas into affordable, deployable, and impactful diagnostics.
At Vijaymala Clinical Laboratory Services LLP, we are committed to developing innovative, low-cost diagnostic platforms for tuberculosis (TB) and other infectious diseases. Our solutions are designed for accessibility, accuracy, and impact in real-world healthcare.
Strong partnerships with universities, incubators, and healthcare networks.
Solutions tailored for low-resource settings to improve accessibility.
Our innovative device combines portability, affordability, and precision to transform TB detection worldwide.
Delivering user-friendly diagnostic tools that require minimal resources while ensuring maximum accuracy and accessibility.
Achieved with nano-bioconjugate immuno-sandwich recognition technology.
Cost-effective, portable, and eco-friendly device for quick TB detection.
Simple Do-It-Yourself testing with a visible color change readout.
Requires only a small sample size and no sophisticated instruments.
Provides both qualitative and quantitative diagnostic results.
Built using straightforward photolithography techniques for scalability.
Nano-bioconjugate immuno-sandwich recognition ensures accuracy and reliability.
Supports non-invasive or minimally invasive sample collection methods.
Leveraging need-based clinically relevant biomarkers, this approach is designed for point-of-care use, particularly in low-resource settings, ensuring accessibility and affordability.
Our research also integrates advanced nanotechnology and biosensors, enhancing sensitivity and ensuring reliable results at the point of care. Collaborations with universities and healthcare institutions help us validate these platforms in real-world scenarios.
Affordable microfluidic devices designed for early detection of tuberculosis in underserved communities.
Utilizing clinically relevant biomarkers to ensure accurate, sensitive, and reliable TB detection.
Portable and cost-effective diagnostics delivering real-time results for doctors and patients in low-resource settings.
We're here to answer your questions & explore new possibilities together.